spacer
home > pmps > autumn 2008 > cross-cultural comments
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Cross-Cultural Comments

The outsourcing of manufacturing and the subsequent transportation and distribution of pharmaceutical products involves the need to work increasingly with different countries – and therefore different cultures – around the world. This brings with it a set of cultural and communication challenges that need to be addressed if the business outcome is to be successful.

One of the challenges of working successfully with different cultures is that business must be conducted professionally within an environment that may have a different perception of what ‘professionalism’ is. In other words, as much as a Middle Eastern government may desire the kudos of manufacturing the region’s newest and most sophisticated medicines in its own back yard...

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Paul Stiff, Intercultural Trainer at Farnham Castle International Briefing & Conference Centre, has spent over 25 years in the healthcare industry working in a variety of roles in Africa, the Middle East and Europe. Working initially in Sales at Novartis Group, and then in Marketing and Senior Management at GSK and more recently Astra Zeneca, he has had plenty of experience of the challenges facing companies manufacturing and selling in markets outside of Europe.
spacer
Paul Stiff
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm announce expansion of partnership with Palvella Therapeutics in developing a new treatment for the debilitating rare disease, pachyonychia congenita

MedPharm Ltd have announced the expansion of their partnership with Palvella Therapeutics, Inc., a Philadelphia-based biopharmaceutical company focused on developing and commercialising therapies for debilitating, rare genetic diseases. To date, MedPharm has employed its world-renowned specialist formulation expertise to support Palvella’s development of a novel, high-strength rapamycin topical formulation for application to the skin (PTX 022) as a disease-modifying treatment for pachyonychia congenita (PC). Most recently, MedPharm has made arrangements to manufacture the clinical (IMP) batches for use in Palvella’s upcoming Phase 2/3 clinical study.
More info >>

White Papers

Investigator Portals: Facilitating and Streamlining Communication & Collaboration with Study Sites

ArisGlobal

ArisGlobal LLC Investigator site personnel are often frustrated with the lack of transparency and communication with their sponsors, leading to significant dissatisfaction and withdrawal from current and future studies. The adoption of investigator portals gives sponsors a platform that fosters collaboration and improves site management. Learn about five key areas of sponsor-investigator site interactions deserving of electronic communication and collaboration. Technology and design aspects are also covered.
More info >>

 
Industry Events

World Pharma Week 2019

17-20 June 2019, Seaport World Trade Center, Boston

World Pharma Week will bring together a unique and international mix of large and medium pharmaceutical and biotech companies, CROs, leading universities and clinical research institutions, emerging companies and tool providers—making it a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement